Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Correction MAR label -Prostatype[®] shows strong data in Asian pilot study

The correction refers to the MAR label. This press release should be with MAR label -Selected for presentation at the Chinese Urology Association’s national congress With the second independent pilot study in the East Asia region showing strong clinical performance, Prostatype Genomics is now reviewing commercialization opportunities in the region.The recent study was conducted in China in collaboration with the Nanjing Drum Tower University Hospital, Jiangsu, and Prostatype Genomics’ partner GloriousMed based in Shanghai. The study indicates that the clinical performance of

Eficode Sweden appoints both a new Country Manager, and its first Head of People and Culture

While Therese Lindepil becomes Country Manager, her predecessor, Christian Johansson, steps into a new role focusing on developing people and culture both at Eficode and among its clients.Stockholm, September 15, 2022 – Eficode today announced Therese Lindepil as the new Country Manager of its Swedish operations. As a part of Eficode’s journey of expansion, a new role has also been created—Head of People and Culture—which former Eficode Sweden Country Manager, Christian Johansson, will be stepping into.  In recent years, Eficode has enjoyed significant growth ,

Read original

New article brings forward support for home dialysis in connection with comorbidities

Redsense Medical notes that a new scientific article is presenting emerging evidence that strengthens the case for home hemodialysis over in-center treatment. Home hemodialysis is the treatment modality in which Redsense’s solutions, which enhance patient safety by automatically and autonomously monitoring the integrity of the blood circuit, provide the most benefit. The article can be found at: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001088 The American Heart Association (AHA), a US non-profit known for publishing guidelines on cardiovascular disease (CVD) and the country’

First day of trading in Railway Metrics and Dynamics

Today is the first day of trading in the technology company Railway Metrics and Dynamics ("RMD"). The company has developed and sells a system platform for real-time analysis and monitoring of transport and infrastructure.Founded in 2011, RMD is a Stockholm-based technology company that has developed a comprehensive systems platform for transport and infrastructure analysis and monitoring. The system platform is based on a patented sensor technology based on algorithms and artificial intelligence through which the user can monitor, for example, locomotives, train carriages or railway

Prostatype[®] shows strong data in Asian pilot study

-Selected for presentation at the Chinese Urology Association’s national congress With the second independent pilot study in the East Asia region showing strong clinical performance, Prostatype Genomics is now reviewing commercialization opportunities in the region.The recent study was conducted in China in collaboration with the Nanjing Drum Tower University Hospital, Jiangsu, and Prostatype Genomics’ partner GloriousMed based in Shanghai. The study indicates that the clinical performance of Prostatype® in East Asian population is in line with the results previously communicated results

Today Agneta Palmér joins Getinge’s executive team

Four years after joining Getinge, Agneta Palmér today takes up her new role as EVP Operational Services and member of the Executive Team. For her, it is a privilege to be part of a company and an industry that evolves health care and helps save lives. “I entered the field of medtech when I joined Getinge four years ago. The values within medtech and especially Getinge resonate with my own ambitions. I like the direction we are going in, as well as the entrepreneurial spirit and to be part of taking responsibility in the greater society,” says Agneta Palmér. Today, Agneta steps

Gasum signs a 10-year PPA with Umicore on wind power

Gasum has agreed to deliver Umicore wind-power generated electricity through a power purchase agreement (PPA). The 10-year contract, commencing in 2025, includes 45 GWh of electricity annually to Umicore’s site in Kokkola, Finland.Gasum has signed a power purchase agreement or PPA with Umicore to supply them with renewable electricity. The electricity will be delivered to Umicore’s site in Kokkola, Finland. The 10-year contract of wind generated energy starts in 2025 and includes 45 GWh annually. Umicore, a Belgian company with over 200 years of history, is a global leader in clean

Orthex has started using renewable raw materials in its SmartStore™ Compact storage products

Orthex Corporation, Press Release 15 September 2022 at 11.00 a.m. EESTOrthex wants to give consumers the opportunity to choose more environmentally friendly products and has started using renewable raw materials in the production of its popular SmartStore™ Compact and Compact Clear storage boxes. The raw materials used are produced by applying a so-called mass balance approach. The mass balance approach means that renewable materials are mixed with fossil materials in the raw material production process. This reduces the amount of fossil-based plastic in the world. The mass balance

Cantargia: Oral presentation of new preclinical CAN10 efficacy data in systemic sclerosis at ACR Convergence

Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today reported new preclinical data demonstrating efficacy of its anti-inflammatory IL1RAP-binding antibody CAN10 in an additional model of systemic sclerosis. CAN10 alleviated disease manifestations in this model, which is one of the most commonly used models of the disease. These findings will be presented in an oral presentation at the annual rheumatology conference ACR Convergence, held in Philadelphia, November 10-14, 2022.“CAN10 continues to demonstrate promising effects in preclinical models of systemic sclerosis and the new data

Orkla acquires leading Polish pizza chain

Orkla has entered an agreement to acquire 74% of the shares in Da Grasso, one of the leading pizza franchise chains in Poland with 193 outlets nationwide.Consumer sales for the chain in 2021 amounted to EUR 53 million, which corresponds to approximately NOK 530 million. Da Grasso had a turnover of EUR 13.6 million in 2021 (NOK 136 million). Normalized EBITDA amounted to EUR 2.5 million in 2021 (NOK 25 million). Da Grasso was established in 1996. The company is headquartered in Łódź and has 51 employees. "Da Grasso is a well-run business that has built an impressive position in the

SRV Group Plc's financial reporting in 2023

SRV GROUP PLC     STOCK EXCHANGE RELEASE     15 SEPTEMBER 2022     11:00 EEST SRV Group Plc's financial reporting in 2023 SRV Group Plc's Financial Statements Bulletin for the year 2022 will be published on Thursday 2 February 2023 at 8:30 a.m. SRV’s Annual Report for 2022 will be published on Wednesday 1 March 2023. In addition, SRV will publish three interim reports in 2023: · January-March on Thursday 27 April 2023 at 8:30 a.m. · January-June on Thursday 20 July 2023 at 8:30 a.m. · January-September Thursday 26 October 2023 at 8:30 a.m. SRV Group Plc's Annual

Norse Atlantic Airways Launches Global Sale

Today, Norse Atlantic Airways launched the great getaway sale with 30,000 seats in Premium and Economy available across all destinations*.“There has never been a better time to book a long weekend city break or to plan the holiday of lifetime thanks to the Norse Atlantic Airways sale. Passengers can enjoy direct flights onboard state of the art Boeing 787 Dreamliners and explore further for less with Norse Atlantic,” said Andrew Hodges, Chief Commercial Officer Norse Atlantic Airways. The large and spacious Boeing 787 Dreamliner cabin offers passengers a relaxed and comfortable travel

Photocure Partner Asieris announces coverage of Hexvix by the Lecheng Global Specialty Drug Insurance

Press release – Oslo, Norway, September 15, 2022: Photocure ASA (PHO: OSE), The Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) has communicated today on the inclusion of Hexvix[®] in the 2022 edition of the Lecheng Global Specialty Drug Insurance Specialty Drug List.As a new specialty drug benefit plan developed under the guidance of the government covering 40 domestic specialty drugs and 60 overseas specialty drugs, the Lecheng Global Specialty Drug Insurance allows Hainan citizens access to more advanced medical resources and comprehensive

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release September 15, 2022 at 10:25 a.m. Nokian Tyres has received an announcement from JPMorgan Chase & Co. on September 14, 2022, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement, the total holding in Nokian Tyres shares owned by the funds and accounts managed by JPMorgan Chase & Co. exceeded the level of 5% of the share capital in Nokian Tyres plc, as a result of share transactions concluded on September 13, 2022. The total holding of JPMorgan Chase & Co. in Nokian Tyres amounted to 6,991,435

The subscription period in Biosergen’s rights issue starts today

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, NEW ZEALAND, SOUTH AFRICA, SOUTH AFRICA, CANADA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Today, September 15, 2022, the subscription period for Biosergen AB’s (publ) (“Biosergen” or the “Company”) upcoming rights issue of units, which was announced on September 2, 2022 (the “Rights Issue”), begins. The subscription period in the Rights Issue runs from and including September 15, 2022, up to and including

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 183 - 15 SEPTEMBER 2022  In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 158/22. A/S Motortramp participates in NORDEN’s share buy-back program by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in NORDEN.     Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Thomas France, Investor

Invest in biotech – funding rounds

In the article series “Investing in biotech”, BioStock addresses important aspects for those who are interested in investing in the biotech sector. In this third part, we take a closer look at the financial side of a biotech company, with a particular focus on share issues.Read the full article at biostock.se: https://www.biostock.se/en/2022/09/invest-in-biotech-funding-rounds/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Tokmanni to open its first Miny store in Jyväskylä and its second in Espoo – Launched in early 2022, the Miny lifestyle brand delights people in different parts of Finland

Tokmanni     Press release     15 September 2022 at 10:15 a.m. “Big on fun, small in price. We are Miny.” Tokmanni launched the Miny lifestyle brand and its shop-in-shop department concept in February 2022. Currently available online and in several Tokmanni stores, Miny will become available in dedicated stores and a growing number of Tokmanni stores. Tokmanni will open its first dedicated stores for its Miny lifestyle brand , which was introduced in early 2022. The Miny store in the Forum Jyväskylä shopping centre  in

Change in Elisa's Executive Board

ELISA STOCK EXCHANGE RELEASE 15 SEPTEMBER 2022 AT 10:15 AM  Ms Katiye Vuorela, Elisa's Executive Vice President, Corporate Communications and member of the Executive Board, has decided to leave the company from 30 September 2022. The process of selecting her successor has begun. “I would like to thank Kati for her valuable and long-term contribution to Elisa and wish her all the best", says Elisa's CEO Veli-Matti Mattila. ELISA CORPORATION  Vesa Sahivirta IR Director +358 50 520 5555  Distribution:  Nasdaq Helsinki Principal Media elisa.com 

Board member leaves Veg of Lund board at his own request

Board member Magnus Nordin has today announced his resignation from the Board of Directors of Veg of Lund AB. The Nomination Committee of Veg of Lund has been conducting a review of the composition of the Board and has identified Anders Gustafsson as a candidate for Board member.“I joined the Veg of Lund board to contribute knowledge about fast-moving consumer goods, FMCG. Now that the company has an updated strategy, a good organisation in place in the UK and an agreement with First Class Brands of Sweden AB for sales processing in the Swedish market, I no longer feel that I contribute

Metso Outotec's Capital Markets Day

Metso Outotec Corporation’s press release on September 15, 2022, at 10:10 a.m. EESTMetso Outotec is holding a Capital Markets Day today, September 15, 2022. A direct webcast  from the event will begin at 1:00 p.m. EEST. The event will cover updates on the company’s strategic development and ongoing actions to meet its financial targets. The presentation materials and recording of the event will be published on company’s website Capital Markets Day 2022 - Metso Outotec (mogroup.com) 

Irisity delivers video analytics for the Parliament of Romania.

Irisity AB (publ) delivers advanced video analytics protecting the Palace of the Parliament in Bucharest.The Palace of the Parliament is the second largest administrative building in the world after the Pentagon in Washington D.C., USA and one of the most expensive buildings ever built. At the time, it cost the equivalent of USD 10 billion to build. This prestigious project, awarded by the Romanian parliament to Irisity and our partners Konica Minolta and Mobotix, includes licenses for several of IRIS advanced algorithms.  Due to the confidential nature of this security asset, we are

Hyperco appoints Joachim Kauppi as chief commercial officer

Helsinki, 15.9.2022     Nordic-based data-center company Hyperco has announced a key appointment: Joachim Kauppi will join the team as chief commercial officer, developing commercial relationships and strengthening the region’s profile as a burgeoning location for sustainable data-center operations. Based in Stockholm, Kauppi will begin his new role immediately.   Kauppi, already one of the area’s most noted talents, joins Hyperco from STACK Infrastructure (formerly DigiPlex), where he headed international sales and helped to showcase the Nordics as a sustainable and

Inhalation Sciences: clarification to previous press releases (published Jan 18, May 5, Aug 4, 2022) regarding the planned FDA study

(Stockholm, 15 September 2022) Inhalation Sciences Sweden AB has been granted a BAA contract for dissolution research purposes. The project objective is to evaluate the discriminative power of the ISAB equipment DissolvIt[® ]by comparing drug formulations, aimed for administration via inhalation, with small differences. The project scope also includes in vitro in vivo correlation (IVIVC). The proposed work was approved by the FDA Center for Drug Evaluation and Research (CDER), not the NCTR, as previously stated.ISAB’s CEO Manoush Masarrat: “This is a great opportunity for ISAB, and we are

There are no items matching the current filter
There are no more items matching the current filter
Back to top